IS4311A - Setin 1H-imíðazól, aðferð til framleiðslu þeirra og notkun þeirra - Google Patents

Setin 1H-imíðazól, aðferð til framleiðslu þeirra og notkun þeirra

Info

Publication number
IS4311A
IS4311A IS4311A IS4311A IS4311A IS 4311 A IS4311 A IS 4311A IS 4311 A IS4311 A IS 4311A IS 4311 A IS4311 A IS 4311A IS 4311 A IS4311 A IS 4311A
Authority
IS
Iceland
Prior art keywords
imidazole
substituted
preparation
Prior art date
Application number
IS4311A
Other languages
English (en)
Icelandic (is)
Inventor
Geerts Jean-Pierre
Motte Geneviève
Differding Edmond
Henichart Jean-Pierre
Original Assignee
Ucb
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb filed Critical Ucb
Publication of IS4311A publication Critical patent/IS4311A/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/58—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IS4311A 1994-12-14 1995-12-08 Setin 1H-imíðazól, aðferð til framleiðslu þeirra og notkun þeirra IS4311A (is)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9425211.1A GB9425211D0 (en) 1994-12-14 1994-12-14 Substituted 1H-imidazoles

Publications (1)

Publication Number Publication Date
IS4311A true IS4311A (is) 1996-06-15

Family

ID=10765918

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4311A IS4311A (is) 1994-12-14 1995-12-08 Setin 1H-imíðazól, aðferð til framleiðslu þeirra og notkun þeirra

Country Status (26)

Country Link
US (1) US5658938A (en, 2012)
EP (1) EP0717037A1 (en, 2012)
JP (1) JPH08208622A (en, 2012)
KR (1) KR960022474A (en, 2012)
CN (1) CN1054376C (en, 2012)
AR (1) AR002257A1 (en, 2012)
AU (1) AU693614B2 (en, 2012)
BG (1) BG63043B1 (en, 2012)
BR (1) BR9505815A (en, 2012)
CA (1) CA2165133A1 (en, 2012)
CZ (1) CZ327195A3 (en, 2012)
EE (1) EE9500064A (en, 2012)
FI (1) FI955927L (en, 2012)
GB (1) GB9425211D0 (en, 2012)
HU (1) HUT73980A (en, 2012)
IL (1) IL116325A (en, 2012)
IS (1) IS4311A (en, 2012)
MX (1) MX9505063A (en, 2012)
NO (1) NO305316B1 (en, 2012)
NZ (1) NZ280646A (en, 2012)
PL (1) PL311736A1 (en, 2012)
RO (1) RO113346B1 (en, 2012)
RU (1) RU2156239C2 (en, 2012)
SK (1) SK155095A3 (en, 2012)
TW (1) TW303362B (en, 2012)
ZA (1) ZA9510554B (en, 2012)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9425211D0 (en) * 1994-12-14 1995-02-15 Ucb Sa Substituted 1H-imidazoles
GB9520150D0 (en) 1995-10-03 1995-12-06 Orion Yhtymae Oy New imidazole derivatives
ZA981080B (en) 1997-02-11 1998-08-12 Warner Lambert Co Bicyclic inhibitors of protein farnesyl transferase
US6503935B1 (en) 1998-08-07 2003-01-07 Abbott Laboratories Imidazoles and related compounds as α1A agonists
US20030073850A1 (en) * 1998-08-07 2003-04-17 Altenbach Robert J. 4-Imidazole derivatives of benzyl and restricted benzyl sulfonamides, sulfamides, ureas, carbamates, and amides and their use
US6388090B2 (en) 2000-01-14 2002-05-14 Orion Corporation Imidazole derivatives
US6362211B2 (en) 2000-05-08 2002-03-26 Orion Corporation Polycyclic indanylimidazoles with alpha2 adrenergic activity
TW200930291A (en) * 2002-04-29 2009-07-16 Bayer Cropscience Ag Pesticidal heterocycles
US20040266776A1 (en) * 2003-06-25 2004-12-30 Gil Daniel W. Methods of preventing and reducing the severity of stress-associated conditions
FI20022007A0 (fi) * 2002-11-08 2002-11-08 Juvantia Pharma Ltd Oy Oromukosaalinen valmiste ja menetelmä sen valmistamiseksi
FI20022159A0 (fi) * 2002-12-05 2002-12-05 Orion Corp Uusia farmaseuttisia yhdisteitä
CA2637261A1 (en) * 2006-01-27 2007-08-02 F. Hoffmann-La Roche Ag Use of 2-imidazoles for the treatment of cns disorders
CN101528710B (zh) * 2006-10-19 2012-11-07 弗·哈夫曼-拉罗切有限公司 氨基甲基-4-咪唑类
AU2007312389B2 (en) * 2006-10-19 2012-02-23 F. Hoffmann-La Roche Ag Aminomethyl-2-imidazoles with affinity with the trace amine associated receptors
CA2668454A1 (en) * 2006-11-02 2008-05-08 F. Hoffmann-La Roche Ag Substituted 2-imidazoles
CA2669112A1 (en) * 2006-11-16 2008-05-22 F. Hoffmann-La Roche Ag Substituted 4-imidazoles
ATE509628T1 (de) * 2006-12-13 2011-06-15 Hoffmann La Roche Neue 2-imidazole als liganden für trace amine associated receptors (taar)
US20080146523A1 (en) * 2006-12-18 2008-06-19 Guido Galley Imidazole derivatives
KR101174191B1 (ko) * 2007-02-02 2012-08-14 에프. 호프만-라 로슈 아게 중추 신경계 장애의 치료용 ｔａａｒ1 리간드로서 2-아미노옥사졸린
EP2398776A1 (en) * 2007-02-13 2011-12-28 Schering Corporation Functionally selective alpha2c adrenoreceptor agonists
BRPI0807961A2 (pt) * 2007-02-13 2017-05-16 Pharmacopeia Llc agonista de alfa2c adrenorreceptor funcionalmente seletivos.
US8470863B2 (en) * 2007-02-13 2013-06-25 Merck Sharp & Dohme, Corp. Derivatives and analogs of chroman as functionally selective ALPHA2C adrenoreceptor agonists
AU2008214774A1 (en) * 2007-02-15 2008-08-21 F. Hoffmann-La Roche Ag 2-aminooxazolines as TAAR1 ligands
WO2009003868A2 (en) 2007-07-02 2009-01-08 F. Hoffmann-La Roche Ag 2 -imidazolines having a good affinity to the trace amine associated receptors (taars)
EP2173719A1 (en) * 2007-07-03 2010-04-14 F. Hoffmann-Roche AG 4-imidazolines and their use as antidepressants
KR101133862B1 (ko) * 2007-07-27 2012-04-06 에프. 호프만-라 로슈 아게 Ｔａａｒ 리간드로서의 2-아제티딘메테인아민 및 2-피롤리딘메테인아민
BRPI0815038A2 (pt) * 2007-08-02 2015-03-17 Hoffmann La Roche Uso de derivados de benzamida para o tratamento de transtornos do cns
EP2185502A1 (en) * 2007-08-03 2010-05-19 F. Hoffmann-Roche AG Pyridinecarboxamide and benzamide derivatives as taar1 ligands
CL2008003553A1 (es) * 2007-12-05 2009-11-27 Grindeks Jsc Proceso para preparar atipamezol o clorhidrato de 5-(2-etil-2,3-dihidro-1h-inden-2-il)-1h-imidazol: y loa compuestos intermediarios considerados en el proceso
EP2257546B1 (en) 2008-02-21 2012-08-15 Merck Sharp & Dohme Corp. Functionally selective alpha2c adrenoreceptor agonists
PE20110215A1 (es) * 2008-07-24 2011-03-31 Hoffmann La Roche Derivados de 4,5-dihidro-oxazol-2-ilo
US8242153B2 (en) * 2008-07-24 2012-08-14 Hoffmann-La Roche Inc. 4,5-dihydro-oxazol-2YL derivatives
US20110190247A1 (en) * 2008-08-04 2011-08-04 Schering Corporation Cyclopropylchromene derivatives as modulators of the alpha-2c receptor
AR073628A1 (es) 2008-10-07 2010-11-17 Schering Corp Analogos de biaril espiroaminooxazolina y espiroaminodiazolina moduladores de receptores adrenergicos alfa2c, composiciones farmaceuticas que los comprenden y uso de los mismos en rinitis alergica,trastornos cardiacos y otras enfermedades
US20100311798A1 (en) * 2009-06-05 2010-12-09 Decoret Guillaume 2-aminooxazolines as taar1 ligands
US8354441B2 (en) * 2009-11-11 2013-01-15 Hoffmann-La Roche Inc. Oxazoline derivatives
US9452980B2 (en) 2009-12-22 2016-09-27 Hoffmann-La Roche Inc. Substituted benzamides
US8673950B2 (en) 2010-11-02 2014-03-18 Hoffmann-Laroche Inc. Dihydrooxazol-2-amine derivatives
US8802673B2 (en) 2011-03-24 2014-08-12 Hoffmann-La Roche Inc Heterocyclic amine derivatives
US9073911B2 (en) 2011-06-09 2015-07-07 Hoffmann-La Roche Inc. Pyrazole derivatives
US9029370B2 (en) 2011-06-10 2015-05-12 Hoffmann-La Roche Inc. Substituted benzamide derivatives
US9181230B2 (en) 2012-01-12 2015-11-10 Hoffmann-La Roche Inc. Morpholine compounds and uses thereof
NZ705154A (en) 2012-09-14 2018-03-23 Hoffmann La Roche Pyrazole carboxamide derivatives as taar modulators for use in the treatment of several disorders, such as depression, diabetes and parkinson’s disease
CN104603129A (zh) * 2012-09-17 2015-05-06 霍夫曼-拉罗奇有限公司 三唑甲酰胺衍生物
WO2015165085A1 (en) 2014-04-30 2015-11-05 F.Hoffmann-La Roche Ag Morpholin-pyridine derivatives
CA2953040A1 (en) 2014-08-27 2016-03-03 F. Hoffmann-La Roche Ag Substituted pyrazino[2,1-a]isoquinoline derivatives for the treatment of cns disorders
CA2954098A1 (en) 2014-08-27 2016-03-03 F. Hoffmann-La Roche Ag Substituted azetidine derivatives as taar ligands
IL261744B (en) * 2016-03-17 2022-07-01 Fmc Corp Process for converting s-enantiomer to its racemic form
AU2017234042B2 (en) 2016-03-17 2020-11-19 F. Hoffmann-La Roche Ag 5-ethyl-4-methyl-pyrazole-3-carboxamide derivative having activity as agonist of TAAR
CN116496261B (zh) * 2023-03-09 2025-06-27 中国人民解放军军事科学院军事医学研究院 4-(1h)-咪唑类衍生物及其医药用途
CN118684628B (zh) * 2024-05-20 2025-06-17 中国人民解放军军事科学院军事医学研究院 取代二氢茚基咪唑类化合物及其制备方法和用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6048972A (ja) * 1983-08-25 1985-03-16 Dai Ichi Seiyaku Co Ltd テトラヒドロナフタレン誘導体
GB2167408B (en) * 1984-11-23 1988-05-25 Farmos Oy Substituted imidazole derivatives and their preparation and use
GB8626287D0 (en) * 1986-11-04 1986-12-03 Ucb Sa Substituted 1h-imidazoles
GB2206880B (en) * 1987-07-16 1991-04-24 Farmos Oy Optical isomers of an imidazole derivative
US5151526A (en) * 1990-10-11 1992-09-29 The United States Of America As Represented By The Secretary Of The Army 4-[1-(1-naphthalenyl)ethyl]-1H-imidazole, method of making and use as an anesthetic
JPH04210680A (ja) * 1990-12-01 1992-07-31 Nissan Chem Ind Ltd イミダゾール誘導体および植物生長調節剤
GB9425211D0 (en) * 1994-12-14 1995-02-15 Ucb Sa Substituted 1H-imidazoles

Also Published As

Publication number Publication date
RU2156239C2 (ru) 2000-09-20
US5658938A (en) 1997-08-19
IL116325A (en) 1999-10-28
HU9503549D0 (en) 1996-02-28
NO955034L (no) 1996-06-17
NO955034D0 (no) 1995-12-12
GB9425211D0 (en) 1995-02-15
FI955927A7 (fi) 1996-06-15
MX9505063A (es) 1997-01-31
FI955927A0 (fi) 1995-12-11
BG100208A (bg) 1996-07-31
AU4036895A (en) 1996-06-20
RO113346B1 (ro) 1998-06-30
EP0717037A1 (fr) 1996-06-19
CA2165133A1 (en) 1996-06-15
TW303362B (en, 2012) 1997-04-21
EE9500064A (et) 1996-06-17
HUT73980A (en) 1996-10-28
BR9505815A (pt) 1998-01-06
BG63043B1 (bg) 2001-02-28
CN1133837A (zh) 1996-10-23
FI955927L (fi) 1996-06-15
AR002257A1 (es) 1998-03-11
AU693614B2 (en) 1998-07-02
CN1054376C (zh) 2000-07-12
SK155095A3 (en) 1997-02-05
NZ280646A (en) 1996-08-27
JPH08208622A (ja) 1996-08-13
CZ327195A3 (en) 1996-07-17
PL311736A1 (en) 1996-06-24
NO305316B1 (no) 1999-05-10
KR960022474A (ko) 1996-07-18
IL116325A0 (en) 1996-03-31
ZA9510554B (en) 1996-06-13

Similar Documents

Publication Publication Date Title
IS4311A (is) Setin 1H-imíðazól, aðferð til framleiðslu þeirra og notkun þeirra
NO20012774L (no) Preparat og metode hvor det gjöres bruk av eteriske planteoljer
HUT77366A (hu) Daganatellenes kakaóextraktumok, ezek előállítási eljárása, valamint alkalmazása
NO964217D0 (no) Fremgangsmåte og anordning relatert til telekommunikasjonssystemer
NO972687L (no) Utskyllingslösning og fremgangsmåte for inhibering av smerte, inflammasjon og spasmer
EE03976B1 (et) Erütromütsiinid ja nende valmistamise meetod
DK0799052T3 (da) Ny antihrombotisk formulering, fremgangsmåde til dens fremstilling og anvendelse deraf
DK0736926T3 (da) Elastisk antennestruktur og fremgangsmåde til fremstilling
DK0664300T3 (da) Pectin, fremgangsmåde og sammensætning
NO973464D0 (no) Forlengingsrör - avskraperpluggapparat og fremgangsmåte
FI20040634A7 (fi) Hajaspekterijärjestelmä ja -menetelmä
DK1041879T3 (da) Desinfektionsmiddel og fremstillingsmetode
DK0656176T3 (da) Pectin, fremgangsmåde og sammensætning
IS1968B (is) Tilbúnar fjölsykrur, aðferð við að framleiða þær og lyfjablöndur sem innihalda þær
DE19681416T1 (de) Drahtloses Telekommunikationssystem sowie Telekommunikationsverfahren
DK0702344T3 (da) Etiketkontinuum og fremgangsmåde til fremstilling deraf
NO983641D0 (no) Fremgangsmåte til behandling og farmasöytisk preparat
NO980257D0 (no) Forankringsinnretning, og fremgangsmåte ved forankring
FI972783A0 (fi) Järjestelmä ja menetelmä liittyen langattomaan viestintään
EE9900141A (et) Keerdotstega suletav pakend ja meetod pakendamiseks
PL306730A1 (en) Derivatives of alpha-pyrimidinylacrylic acid, method of obtaining them and their applications
DK0732276T3 (da) Spraydåse og fremgangsmåde til dens fremstilling
PL328824A1 (en) Novel triazolopurines, method of obtaining them and their application as drugs
PL331287A1 (en) Substituted derivatives of pyrazoyl-pyrazole, method of obtaining them and their application as herbicides
PL320360A1 (en) Iminoxymethylene anilides, method of obtaining them and their application